Related references
Note: Only part of the references are listed.Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers
Francesco Tandoi et al.
DIGESTIVE AND LIVER DISEASE (2014)
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B infection post-liver transplantation
Tomohiro Tanaka et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Balancing Utility and Need by Means of Donor-to-Recipient Matching: A Challenging Problem
A. W. Avolio et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Akinobu Takaki et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study
Mario Angelico et al.
JOURNAL OF HEPATOLOGY (2013)
Current management and perspectives for HCV recurrence after liver transplantation
Audrey Coilly et al.
LIVER INTERNATIONAL (2013)
Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: A 13-year experience
Humberto E. Bohorquez et al.
LIVER TRANSPLANTATION (2013)
Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience
Matthew S. Chang et al.
TRANSPLANTATION (2013)
Use of Liver Grafts From Anti-Hepatitis B Core-Positive Donors: A Multicenter Study in Argentina
S. Marciano et al.
TRANSPLANTATION PROCEEDINGS (2013)
An Examination of Liver Offers to Candidates on the Liver Transplant Wait-List
Jennifer Cindy Lai et al.
GASTROENTEROLOGY (2012)
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation
E. Cholongitas et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis
Catherine L. Skagen et al.
CLINICAL TRANSPLANTATION (2011)
Adult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region
Hee Yeon Kim et al.
GUT AND LIVER (2011)
Joint Impact of Donor and Recipient Parameters on the Outcome of Liver Transplantation in Germany
Nils R. Fruehauf et al.
TRANSPLANTATION (2011)
Liver grafts from anti-hepatitis B core positive donors: A systematic review
Evangelos Cholongitas et al.
JOURNAL OF HEPATOLOGY (2010)
Survival After Orthotopic Liver Transplantation: The Impact of Antibody Against Hepatitis B Core Antigen in the Donor
Lei Yu et al.
LIVER TRANSPLANTATION (2009)
The Clinical Relevance of the Anhepatic Phase During Liver Transplantation
Alexander J. C. IJtsma et al.
LIVER TRANSPLANTATION (2009)
Hepatitis B Virus Prevention Strategies for Antibody to Hepatitis B Core Antigen-Positive Liver Donation: A Survey of North American, European, and Asian-Pacific Transplant Programs
Robert Perrillo
LIVER TRANSPLANTATION (2009)
Survival Benefit After Liver Transplantation: A Single European Center Experience
Matteo Ravaioli et al.
TRANSPLANTATION (2009)
The natural history of recurrent hepatitis C and what influences this
Edward J. Gane
LIVER TRANSPLANTATION (2008)
Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation
Jens Rosenau et al.
LIVER TRANSPLANTATION (2007)
Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation
S. Weiss et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Time course of intraoperative cytokine levels in liver transplant recipients
F. Santiago et al.
TRANSPLANTATION PROCEEDINGS (2006)
Early postoperative response of cytokines in liver transplant recipients
L. Hassan et al.
TRANSPLANTATION PROCEEDINGS (2006)
Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor
RD Yen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Characteristics associated with liver graft failure: The concept of a donor risk index
S Feng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Donation after cardiac death - The University of Wisconsin experience with liver transplantation
DP Foley et al.
ANNALS OF SURGERY (2005)
Use of hepatitis B core anti body-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and lamivudine
A Jain et al.
TRANSPLANTATION PROCEEDINGS (2005)
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: Meta-analysis of clinical trials
F Fabrizi et al.
TRANSPLANTATION (2004)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up
UP Neumann et al.
TRANSPLANTATION (2004)
Perioperative cytokines during orthotopic liver transplantation without venovenous bypass
P Faybik et al.
TRANSPLANTATION PROCEEDINGS (2003)
Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: A survey of current practice in the united states
JR Butron et al.
LIVER TRANSPLANTATION (2003)
Effect of proinflammatory cytokines (IL-6, TNF-α, IL-1β) on hemodynamic performance during orthotopic liver transplantation
J Arranz et al.
TRANSPLANTATION PROCEEDINGS (2003)
The utility of marginal donors in liver transplantation
RW Busuttil et al.
LIVER TRANSPLANTATION (2003)
Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
GE Loss et al.
LIVER TRANSPLANTATION (2003)
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
M Berenguer et al.
HEPATOLOGY (2002)
Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age
N Cuende et al.
TRANSPLANTATION (2002)
The association between hepatitis C infection and survival after orthotopic liver transplantation
LM Forman et al.
GASTROENTEROLOGY (2002)
Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
H Marusawa et al.
HEPATOLOGY (2000)
Share Paper
